drugset / Trial / NCT00422552

Effect of Indacaterol on Inspiratory Capacity and Lung Function in Patients With COPD Versus Placebo and Formoterol

NCT00422552

Phase 1/2 Completed 30 enrolled Novartis
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to assess the change in inspiratory capacity and lung function in patients with chronic obstructive pulmonary disease when treated with indacaterol compared to placebo and formoterol.

Timeline

Start
2006-09
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Indacaterol Other / unclassified